SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
CMS Reimbursement changes raging like a beast to belabor several HA market players For Q322, the true im...
As the CEO of SmartTRAK, I understand Medtech executives often drown in data and need quick, easy access...
SmartTRAK interviews Bolt Navigation CEO Patrick West to learn more about the Company and its potentiall...
Even stronger foreign exchange headwinds inhibit revenue growth from steadily improving elective procedu...
Do you love keeping up with the latest trends in the Spine and OrthoBiologics/Regen medicine markets? Ar...
The potential of US reimbursement changes to Skin Substitutes weighed heavily on companies at SAWC Fall,...
In the market for Trauma & Extremities, companies continue to innovate with new product introduction...
Highlighting the economic conversation at AAHKS 2022 changing the landscape of joint replacement At the ...
For the first time in recent years, robotics was not a main headline in the academic program at NASS 202...
SmartTRAK looks at recent currency fluctuations and the impact on company performance and underlying gro...
Login